Equity Profile

IRON

Disc Medicine, Inc.

Health CareBiotechnology$2.9B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Disc Medicine, Inc. is a biotechnology company focused on developing innovative therapies for patients with rare blood disorders....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, which investors will closely analyze.

N/A

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

IRON Q2-2026 Earnings Preview

Context

Company Snapshot

Disc Medicine, Inc. is a biotechnology company focused on developing innovative therapies for patients with rare blood disorders. As part of the health care sector, its advancements could significantly impact treatment options and patient outcomes in this niche market.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-39.84%

Avg Stock Reaction

+0.34%

Last Quarter Recap

In Q1-2026, Disc Medicine reported an EPS of -$1.65, which was worse than the expected -$1.55. The stock reacted minimally, declining by 0.07% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Disc Medicine are cautious due to its recent earnings history, where it has consistently missed EPS estimates. Investors will be looking for signs of improvement or any positive developments.

Bull Case

If the company can show a significant reduction in losses or even a surprise positive EPS, it could indicate a turnaround and boost investor confidence.

Bear Case

Continued misses on EPS and revenue could lead to further declines in stock price, as investors may lose faith in the company's growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

The EPS figure is crucial as it will indicate whether the company is making progress towards profitability or continuing to struggle.

What revenue figures will be reported?

Revenue is a key metric that reflects the company's sales performance and market demand, which investors will closely monitor for signs of growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a turnaround, as recent product developments could lead to improved sales figures.

Supporting Evidence

Options are pricing a 22.14% move, indicating expectations for significant volatility.

The company's recent product advancements may not be fully reflected in current estimates.

Key Risk

If the EPS comes in better than -$1.50, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be critical in determining if the company can turn around its recent performance and regain investor confidence.

Bull Confirmed If

An EPS improvement to -$1.50 or better, alongside revenue growth, would confirm a positive outlook.

Bear Confirmed If

An EPS of -$1.75 or worse would reinforce concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±22.14%

Historical Avg

±2.8%

Pricing rich

The options market is pricing a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±22.1% while IRON has averaged ±2.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

32.9%

Calls (200)P/C Ratio: 1.00Puts (200)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Disc Medicine beats expectations, history suggests a potential average move of +0.64%, confirming a positive shift in investor sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see minimal movement, reflecting ongoing uncertainty.

Miss

Should the company miss expectations, history suggests an average decline of +0.64%, which could further dampen investor confidence.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements.
2Management's commentary on market demand and sales strategies.
3Insights into cost management and operational efficiency.
4Any guidance on future revenue expectations.
5Discussion of competitive landscape and market positioning.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Disc Medicine, Inc. is a biotechnology company focused on developing innovative therapies for patients with rare blood disorders....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, which investors will closely analyze.

N/A

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

IRON Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-39.84%

Avg Stock Reaction

+0.34%

Last Quarter Recap

In Q1-2026, Disc Medicine reported an EPS of -$1.65, which was worse than the expected -$1.55. The stock reacted minimally, declining by 0.07% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If the company can show a significant reduction in losses or even a surprise positive EPS, it could indicate a turnaround and boost investor confidence.

Bear Case

Continued misses on EPS and revenue could lead to further declines in stock price, as investors may lose faith in the company's growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

The EPS figure is crucial as it will indicate whether the company is making progress towards profitability or continuing to struggle.

What revenue figures will be reported?

Revenue is a key metric that reflects the company's sales performance and market demand, which investors will closely monitor for signs of growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a turnaround, as recent product developments could lead to improved sales figures.

Supporting Evidence

Options are pricing a 22.14% move, indicating expectations for significant volatility.

The company's recent product advancements may not be fully reflected in current estimates.

Key Risk

If the EPS comes in better than -$1.50, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be critical in determining if the company can turn around its recent performance and regain investor confidence.

Bull Confirmed If

An EPS improvement to -$1.50 or better, alongside revenue growth, would confirm a positive outlook.

Bear Confirmed If

An EPS of -$1.75 or worse would reinforce concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±22.14%

Historical Avg

±2.8%

Pricing rich

The options market is pricing a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±22.1% while IRON has averaged ±2.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

32.9%

Calls (200)P/C Ratio: 1.00Puts (200)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Disc Medicine beats expectations, history suggests a potential average move of +0.64%, confirming a positive shift in investor sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see minimal movement, reflecting ongoing uncertainty.

Miss

Should the company miss expectations, history suggests an average decline of +0.64%, which could further dampen investor confidence.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements.
2Management's commentary on market demand and sales strategies.
3Insights into cost management and operational efficiency.
4Any guidance on future revenue expectations.
5Discussion of competitive landscape and market positioning.